Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZeNix: Linezolid Dosing in BPaL Regimen for Drug-Resistant TB
NCT03086486Phase 3Completed
- Sponsor
- TB Alliance
- Start
- Nov 2017
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of linezolid in Tuberculosis (TB), pulmonary tuberculosis (TB), sponsored by TB Alliance. Started Nov 2017; status: completed.
02
Drugs
linezolid
03
Conditions
Tuberculosis (TB)pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT03086486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03086486.